28. PRELIMINARY EVALUATION OF THE DIAGNOSTIC VALUE OF HFLC IN DIFFERENTIATING DENGUE FEVER FROM OTHER FEBRILE ILLNESSES
Main Article Content
Abstract
Abstract: Dengue fever (DF) remains a primary global health concern. High Fluorescence Lymphocyte Count (HFLC) reflects the immune response to infection by quantifying antibody-secreting cells (ASC), such as plasmablasts/plasma cells. ASCs are known to increase markedly in dengue compared to other febrile illnesses (OFIs).
Objective: This study aimed to preliminarily evaluate the diagnostic value of HFLC in distinguishing dengue fever from other febrile illnesses.
Methods: A cross-sectional study was conducted on 317 patients presenting with fever on admission. Clinical features and laboratory parameters, including HFLC# and HFLC%, were collected. Patients were categorized into the dengue infection (DI) group (n = 267) and the OFI group (n = 50).
Results: The DI group had significantly higher median HFLC# (0.11 G/L) and HFLC% (5.2%) compared to the OFI group (0.01 G/L and 0.20%, respectively; p < 0.001). ROC analysis showed good diagnostic performance, with AUCs of 0.794 (HFLC#) and 0.842 (HFLC%). A cut-off value of 0.025 G/L for HFLC# yielded 70.4% sensitivity and 78.0% specificity. For HFLC%, a threshold of 0.75% resulted in 70.8% sensitivity and 88.0% specificity.
Conclusion: HFLC demonstrates potential as a rapid and accessible marker for differentiating dengue fever from other febrile illnesses in clinical practice.
Article Details
Keywords
Dengue fever, HFLC, diagnosis.
References
[2] Ha, V. H. ., Ha, T. T. T. ., Thai, P. Q. ., Nghia, N. D. ., Nam, V. S. ., & Duong, T. N. . (2022). Sốt xuất huyết dengue tại Việt Nam giai đoạn 1999 – 2020. Vietnam J. Prev. Med. 32, 9–15 (2022). doi:https://doi.org/10.51403/0868-2836/2022/603.
[3] Kularatne, S. A. M. Dengue fever. BMJ 351, h4661 (2015). doi:10.1136/bmj.h4661.
[4] Oehadian, A. et al. New parameters available on Sysmex XE-5000 hematology analyzers contribute to differentiating dengue from leptospirosis and enteric fever. Int. J. Lab. Hematol. 37, 861–868 (2015). doi:10.1111/ijlh.12422.
[5] Low, J. G. H. et al. The Early Clinical Features of Dengue in Adults: Challenges for Early Clinical Diagnosis. PLoS Neglected Tropical Diseases vol. 5 (2011). doi:10.1371/journal.pntd.0001191.
[6] Chen, L. H. & Wilson, M. E. Dengue and chikungunya infections in travelers. Curr. Opin. Infect. Dis. 23, 438–444 (2010). doi:10.1097/QCO.0b013e32833c1d16.
[7] Linssen, J. et al. Identification and quantification of high fluorescence-stained lymphocytes as antibody-synthesizing/secreting cells using the automated routine hematology analyzer XE-2100. Cytometry B. Clin. Cytom. 72, 157–166 (2007). doi:10.1002/cyto.b.20150.
[8] Wrammert, J. et al. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J. Virol. 86, 2911–2918 (2012). doi:10.1128/JVI.06075-11.
[9] Lee, H. et al. Comparison of Six Commercial Diagnostic Tests for the Detection of Dengue Virus Non-Structural-1 Antigen and IgM/IgG Antibodies. Ann. Lab. Med. 39, 566–571 (2019). doi:10.3343/alm.2019.39.6.566.